Hepatitis C Drugs
Mar 01, 2017
Hepatitis C drugs re-energize global fight over patents
The liver disease hepatitis C is the new battleground for lawsuits intended to slash the cost of life-saving medicines. In February alone, five suits were filed in India and Argentina claiming that the latest class of antiviral drugs does not warrant the 20-year patent monopoly that manufacturers have sought in thos...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
